177
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Aggressive Natural Killer-cell Leukemia: Report of Five Cases and Review of the Literature

, &
Pages 2427-2439 | Published online: 01 Jul 2009

References

  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lym-phoma Study Group", Blood, 84(5), 1361–1392.
  • Chan, J.K.C., Wong, K.F., Jaffe, E.S. and Ralficiaer, E. (2001) "Aggressive NK-Cell Leukemia". In World Health Organization Classification of Tumors, Tumors of Haematopoietic and Lymphoid Tissues, edited by E.S. Jaffe, N.L. Harris, H. Stein and J.W. Vardiman. Pp. 197–200. Lyon: IARC Press.
  • Fernandez, L.A., Pope, B., Lee, C. and Zayed, E. (1986) "Aggressive Natural Killer cell leukemia in an adult with establish-ment of an NK cell line", Blood, 67, 925–930.
  • Koizumi, S., Selci, H., Tachinami, T., Taniguchi, M., Matsuda, A., Taga, K., et al. (1986) "Malignant clonal expansion of large granular lymphocytes with a Leu-11 + Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleulcin 2", Blood, 68, 1065 — 1073.
  • Kotani, H., Ishikura, H., Hayashi, H. and Tsunematsu, T. (1988) "Aggressive LGL leukemia associated with recurrent fever and gastrointestinal ulcer", Acta Haematologica Japonica, 51, 272 (Japanese abstract).
  • Ohno, Y., Kamezalci, H., Amano, H., Imanaka, T., Takahashi, Y., Arita, H., et al. (1987) "T3-, leu 1 1 +, leu7- LGL leukemia with germ line configuration of TCR gene", Acta Haematologica Japonica, 50, 338 (Japanese abstract).
  • Fujii, H., Maekawa, T., Kano, T., Ohno, T., Arita, H., Tanikawalci, M., et al. (1987) "An aggressive LGL leukemia", 29th annual meeting of Japan Society of Clinical Hematology, 423 (Japanese abstract).
  • Maekawa, T., Fujii, H., Doi, S., Takahashi, T., Yokota, S., Horiike, S., et al. (1986) "Aggressive LGL leukemia with E +, OKT +, OKT11 +, OKIa-1 +, Leu7-, Leu 11- surface phenotype", 28th Annual Meeting of Japan Society of Clinical Hematology, 272 (Japanese abstract).
  • Imamura, N., Kusunolci, Y., Kawa-Ha, K., Yumura, K., Hara, J., Oda, K., et al. (1990) "Aggressive natural killer cell leukaemia/ lymphoma: report of four cases and review of the literature", British Journal of Haematology, 75, 49–59.
  • Sheridan, W., Winton, E.F., Chan, W.C., Gordon, D.S., Vogler, W.R., Phillips, C., et al. (1988) "Leukemia of non-T lineage natural killer cells", Blood, 72(5), 1701–1707.
  • Imashuku, S., Okuda, T., Yoshihara, T., Ikushima, S. and Hibi, S. (1991) "Cytokine levels in aggressive natural killer cell leukaemia and malignant histiocytosis", British Journal of Haematology, 79, 132–141.
  • Hart, D.N.J., Baker, B.W., Inglis, M.J., Nimmo, J.C., Starlong, G.C., Deacon, E., et al. (1992) "Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells", Blood, 79(8), 2116–2123.
  • Sun, T., Brody, J., Susin, M., Marino, J., Teichberg, S., Koduru, P., et al. (1993) "Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity", American Journal of Surgical Pathology, 17(12), 1289 — 1299.
  • Soler, J., Bordes, R., Ortuno, F., Montagud, M., Martorell, J., Pons, C., et al. (1994) "Aggressive natural killer cell leukaemia/ lymphoma in two patients with lethal midline granuloma", British Journal of Haematology, 86, 659–662.
  • Nakamura, S., Suchi, T., Koshikawa, T., Kitoh, K., Koike, K., Komatsu, H., et al. (1995) "Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract", American Journal of Surgical Pathology, 19(3), 284 — 296.
  • Kwong, Y.L., Chan, A.C.L., Liang, R., Chiang, A.K.S., Chim, CS., Chan, T.K., et al. (1997) "CD56 + NK lymphomas: clinicopathological features and prognosis", British Journal of Haematology, 97, 821 — 829.
  • Chan, J.K.C., Sin, V.C., Wong, K.F., Ng, CS., Tsang, W.Y.W., Chan, C.H., et al. (1997) "Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm", Blood, 89(12), 4501 — 4513.
  • De Lord, C., Mercieca, J., Ashton-Key, M., Singh, L., Ryley, S., Isaacson, P., et al. (1998) "Aggressive NK cell lymphoma preceded by a ten year history of neutropenia associated with large granular lymphocyte lymphocytosis", Leukemia and Lymphoma, 31, 417 —421.
  • Dunkley, S., Gibson, J., Macicinlay, N. and Joshua, D. (1998) "Aggressive natural killer cell leukemia/lymphoma", Pathology, 30, 157— 159.
  • Akashi, K. and Mizuno, S.I. (2000) "Epstein-Barr-infected natural killer cell leukemia", Leukemia and Lymphoma, 40(1–2), 57 — 66.
  • Taniwalci, M., Tagawa, S., Nishigalci, H., Horiike, S., Misawa, S., Shimazalci, C., et al. (1990) "Chromosomal abnormalities define clonal proliferation in CD3- large granular lymphocyte leukemia", American Journal of Hematology, 33, 32— 38.
  • Ohno, T., Kanoh, T., Arita, Y., Fujii, H., Kuribayashi, K., Masuda, T., et al. (1988) "Fulminant clonal expansion of large granular lymphocytes", Cancer, 62, 1918–1927.
  • Chan, W.C., Gu, L.B., Masih, A., Nicholson, J., Vogler, W.R., Yu, G., et al. (1992) "Large granular lymphocyte proliferation with the natural killer-cell phenotype", American Journal of Clinical Pathol-ogy, 97(3), 353–358.
  • Okuda, T., Sakamoto, S., Deguchi, T., Misawa, S., Kashima, K., Yoshihara, T., et al. (1991) "Hemophagocytic Syndrome associated with aggressive natural killer cell leukemia", American Journal of Hematology, 38, 321–323.
  • Sun, T., Schulman, P., Katz, J., Susin, M., Brody, J., Koduru, P., et al. (1992) "A study of lymphoma of large granular lymphocytes with modern modalities: report of two cases and review of the literature", American Journal of Hematology, 40, 135— 145.
  • Wong, K.F., Chan, J.K.C., Ma, S.K. and Lai, K.Y. (1995) "Aggressive pleomorphic CD2 +, CD3-, CD56 + lymphoma with t(5;9)(q31;q34) abnormality", Cancer Genetics Cytogenetics, 82, 73–75.
  • Kwong, Y.L., Wong, K.F., Chan, L.C., Liang, R.H.S., Chan, J.K.C., Lin, C.K., et al. (1995) "Large granular lymphocyte leukemia. A study of nine cases in a Chinese population", American Journal Clinical Pathology, 103(1), 76–81.
  • Shimodaira, S., Ishida, F., Kobayashi, H., Mahbub, B., Kawa-Ha, K. and Kitano, K. (1995) "The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage", British Journal of Haematology, 90, 578–584.
  • Emile, J.F., Boulland, ML., Haioun, C., Kanavaros, P., Petrella, T., Delfau-Larue, M.H., et al. (1996) "CD5- CD56 + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas", Blood, 87(4), 1466 — 1473.
  • Mateu, R., Badell, I., Alcala, A., Estivill, C., Rubiol, E., Nomdedeu, J., et al. (1998) "Aggressive natural killer cell leukemia: report of a case in a Caucasian boy. (letter)", Haematologica, 83, 190–192.
  • Camera, A., Pezzullo, L., Villa, MR., Luciano, L., Pane, F., Izzo, B., et al. (2000) "Coexistence of two distinct cell populations (CD56 + TcRyS + and CD56 + TcRy5-) in a case of aggressive CD56 + lymphoma/leukemia", Haematologica, 85, 496— 501.
  • Hamaguchi, H., Yamaguchi, M., Nagata, K., Koike, E., Imagun-bai, M., Tsurukubo, Y., et al. (2001) "Aggressive NK cell lymphoma/leukemia with clonal der(3)41;3)(q12;p25), del(6)(q13) and del(13)(q12q14)", Cancer Genetics and Cytogenetics, 130, 150 — 154.
  • Kawa-Ha, K., Ishihara, S., Ninomiya, T., Yumura-Yagi, K., Hara, J., Murayama, F., et al. (1989) "CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA", Journal of Clinical Investigation, 84, 51— 55.
  • Ohno, Y., Amakawa, R., Fukuhara, S., Huang, CR., Kamesalci, H., Amano, H., et al. (1989) "Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromo-some abnormality", Cancer, 64(1), 63–67.
  • Oshimi, K., Yamada, 0., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., et al. (1993) "Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders", Leukemia, 7(6), 782–788.
  • Mori, K.L., Egashira, M. and Oshimi, K. (2001) "Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis", British Journal of Haematology, 115, 225–228.
  • Nichols, G.E., Normansell, D.E. and Williams, M.E. (1994) "Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma", Modern Pathology, 7(8), 819–824.
  • Matano, S., Nakamura, S., Nakamura, S., Annen, Y., et al. (1999) "Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association", Acta Haematologica, 101, 206— 208.
  • Oshimi, K. (1988) "Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature", Leukemia, 2(10), 617 — 627.
  • Ohnuma, K., Toyodo, Y., Nishihira, H., Iguchi, A., Honda, K., Nagao, T., et al. (1997) "Aggressive natural killer (NK) cell lymphoma: report of a pediatric case and review of the literature", Leukemia and Lymphoma, 25, 387–392.
  • Natkunam, Y., Smoller, BR., Zehnder, J.L., Dorfman, R.F. and Warnke, R.A. (1999) "Aggressive cutaneous NK and NK-like T-cell lymphomas. Clinicopathologic, immunohistochemical and molecu-lar analyses of 12 cases", American Journal of Surgical Pathology, 23(5), 571 — 581.
  • Ohshima, K., Suzumiya, J., Sugihara, M., Kanda, M., Shimazalci, K., Kawasaki, C., et al. (1999) "Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including all3, y/ T-cell and natural killer cell types", Virchows Archive, 435, 92–100.
  • Ohshima, K., Kikuchi, M., Mizuno, S., Akashi, K., Moriyama, K., Yoneda, S., et al. (1995) "Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr virus-containing natural killer cell leukemia/lymphoma and T-cell lymphoma; mimicking malignant histiocytosis", Hematological Oncology, 13, 83–97.
  • Ohshima, K., Liu, Q., Koga, T., Suzumiya, J. and Kikuchi, M. (2002) "Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma — natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types", Virchows Archive, 440, 425 — 435.
  • Cunningham, BA., Hemperly, J.J., Murray, BA., Prediger, E.A., Brackenbury, R. and Edelman, G.M. (1987) "Neural Cell Adhesion Molecule: Structure, Immunoglobulin-like domains, cell surface modulation and alternative RNA splicing", Science, 236, 799 — 806.
  • Rutishauser, U., Acheson, A., Hall, AK., Mann, D.M. and Sunshine, J. (1988) "The Neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions", Science, 240, 53–57.
  • Kern, W.F., Spier, CM., Hanneman, E.H., Miller, T.P., Matzner, M. and Grogan, T.M. (1992) "Neural cell adhesion molecule—positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement", Blood, 79(9), 2432 — 2437.
  • Sato, K., Kimura, F., Nakamura, Y., Murakami, H., Yoshida, M., Tanaka, M., et al. (1996) "An aggressive nasal lymphoma accompanied by high levels of soluble FAS ligand", British Journal of Haematology, 94, 379–382.
  • Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., et al. (1996) "Fos ligand in human serum", Nature Medicine, 2, 317–322.
  • Akashi, K., Hayashi, S., Gondo, H., Mizuno, S., Harada, M., Tamura, K., et al. (1994) "Involvement of interferon-y and macrophage colony-stimulating factor in pathogenesis of haemo-phagocytic lymphohistiocytosis in adults", British Journal of Haematology, 87, 243–250.
  • Wong, K.F. and Chan, J.K.C. (1992) "Reactive hemophagocytic syndrome — a clinicopathologic study of 40 patients in an oriental population", American Journal of Medicine, 93, 177 — 180.
  • Pelicci, PG., Allavena, P., Subar, M., Rambaldi, A., Pirelli, A., Di Bello, M., et al. (1987) "T cell receptor (a, /3, y) gene rearrangements and expression in normal and leukemic large granular lymphocytes/ natural killer cells", Blood, 70(5), 1500–1508.
  • Sivakumaran, M., Richards, S.J., Hunt, KM., Steed, A.J., Bynoe, A.G., Morgan, MM., et al. (1991) "Patterns of CD16 and CD56 expression in persistent expansions of CD3 + Nka + lymphocytes are predictive for clonal T-cell receptor gene rearrangements", British Journal of Haematology, 78, 368–377.
  • Kelly, A., Richards, Si., Sivakumaran, M., Shiach, C., Stewart, A.D., Roberts, BE., et al. (1994) "Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies", Journal of Clinical Pathology, 47, 399 — 404.
  • Wong, K.F., Chan, J.K.C. and Kwong, Y.L. (1997) "Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia", British Journal of Haema-tology, 98, 922–926.
  • Wong, K.F., Zhang, Y.M. and Chan, J.K.C. (1999) "Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia — Is there a consistent pattern?", Leukemia and Lymphoma, 34(3–4), 241–250.
  • Schouten, H.C., Sanger, W.G., Weisenburger, D.D. and Armitage, .1.0. (1990) "Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma", Cancer Genet-ics and Cytogenetics, 47, 73–82.
  • Gaidano, G., Hauptschein, R.S., Parsa, N.Z., Offit, K., Rao, PH., Lenoir, G., et al. (1992) "Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma", Blood, 80, 1781–1787.
  • Kanegane, H., Yachie, A., Miyawalci, T. and Tosato, G. (1998) "EBV-NK cells interactions and lymphoproliferative disorders", Leukaemia and Lymphoma, 29, 491 — 498.
  • Mizuno, S., Akashi, K., Ohshima, K., Iwasaki, H., Miyamoto, T., Uchida, N., et al. (1999) "Interferon-y prevents apoptosis in Epstein-Barr Virus-infected Natural Killer cell leukaemia in an autocrine fashion", Blood, 93(10), 3494–3504.
  • Ross, M.E. and Caligiuri, M.A. (1997) "Cytolcine-induced apopto-sis of human natural killer cells identifies a novel mechanism to regulate the innate immune response", Blood, 89(3), 910–918.
  • Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., et al. (1991) "Induction of bc1-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death", Cell, 65(7), 1107–1115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.